Carbamazepine



Indications and Reactions:

Role Indications Reactions
Primary
Epilepsy 33.3%
Convulsion 14.5%
Product Used For Unknown Indication 9.5%
Drug Use For Unknown Indication 5.6%
Trigeminal Neuralgia 5.4%
Bipolar Disorder 5.2%
Grand Mal Convulsion 3.1%
Partial Seizures 3.0%
Depression 2.8%
Hypertension 2.5%
Schizophrenia 2.3%
Complex Partial Seizures 2.2%
Neuralgia 2.1%
Petit Mal Epilepsy 1.9%
Psychotic Disorder 1.5%
Pain 1.3%
Bipolar I Disorder 1.1%
Schizoaffective Disorder 1.0%
Affective Disorder 0.9%
Temporal Lobe Epilepsy 0.8%
Convulsion 9.9%
Vomiting 7.7%
Stevens-johnson Syndrome 7.2%
Toxic Epidermal Necrolysis 6.8%
Completed Suicide 6.7%
Status Epilepticus 6.6%
Rash 6.3%
Suicide Attempt 5.8%
Somnolence 4.8%
Pyrexia 4.6%
Toxicity To Various Agents 3.9%
Petit Mal Epilepsy 3.7%
Drug Rash With Eosinophilia And Systemic Symptoms 3.5%
Maternal Drugs Affecting Foetus 3.5%
White Blood Cell Count Increased 3.5%
Drug Ineffective 3.4%
Product Substitution Issue 3.1%
Drug Interaction 3.0%
Treatment Noncompliance 3.0%
Tremor 3.0%
Secondary
Product Used For Unknown Indication 25.0%
Epilepsy 23.4%
Drug Use For Unknown Indication 15.6%
Convulsion 7.3%
Drug Abuse 3.0%
Bipolar Disorder 2.4%
Schizophrenia 2.4%
Trigeminal Neuralgia 2.2%
Depression 2.1%
Pain 2.0%
Infantile Spasms 2.0%
Hypertension 1.8%
Drug Exposure During Pregnancy 1.6%
Insomnia 1.6%
Partial Seizures 1.4%
Mental Disorder 1.4%
Migraine 1.3%
Grand Mal Convulsion 1.3%
Irritability 1.2%
Alcoholic Psychosis 1.2%
Completed Suicide 11.6%
Vomiting 8.4%
Somnolence 7.2%
Toxicity To Various Agents 6.9%
Convulsion 5.6%
Stevens-johnson Syndrome 5.5%
Drug Ineffective 5.2%
Epilepsy 4.6%
Hyponatraemia 4.2%
Suicide Attempt 4.2%
Toxic Epidermal Necrolysis 4.1%
Status Epilepticus 4.0%
Drug Rash With Eosinophilia And Systemic Symptoms 3.9%
Tachycardia 3.9%
Respiratory Arrest 3.8%
Drug Toxicity 3.7%
Death 3.4%
Weight Decreased 3.4%
Thrombocytopenia 3.3%
Colitis Microscopic 3.1%
Concomitant
Product Used For Unknown Indication 20.1%
Epilepsy 17.6%
Drug Use For Unknown Indication 12.7%
Convulsion 6.7%
Hypertension 5.8%
Depression 5.3%
Pain 5.0%
Bipolar Disorder 4.4%
Multiple Sclerosis 4.2%
Rheumatoid Arthritis 3.6%
Schizophrenia 2.4%
Relapsing-remitting Multiple Sclerosis 1.7%
Insomnia 1.5%
Partial Seizures 1.4%
Constipation 1.3%
Anxiety 1.3%
Osteoporosis 1.3%
Prophylaxis 1.3%
Trigeminal Neuralgia 1.2%
Cardiac Disorder 1.1%
Vomiting 10.6%
Weight Increased 9.7%
Convulsion 9.2%
Weight Decreased 8.7%
Urinary Tract Infection 5.6%
Tremor 5.5%
Status Epilepticus 5.0%
Somnolence 4.7%
Epilepsy 4.3%
Vision Blurred 3.9%
Pyrexia 3.8%
Pneumonia 3.7%
Suicidal Ideation 3.7%
Drug Ineffective 3.6%
Rash 3.3%
Loss Of Consciousness 3.0%
Suicide Attempt 3.0%
White Blood Cell Count Decreased 3.0%
Psychotic Disorder 2.9%
Type 2 Diabetes Mellitus 2.9%
Interacting
Product Used For Unknown Indication 19.8%
Epilepsy 17.0%
Drug Use For Unknown Indication 15.0%
Convulsion 9.7%
Systemic Antiviral Treatment 5.1%
Hypertension 4.9%
Hiv Infection 4.6%
Agitation 2.8%
Abnormal Behaviour 2.6%
Convulsion Prophylaxis 2.2%
Depression 2.0%
Skin Lesion 2.0%
Neuralgia Nos 1.8%
Trigeminal Neuralgia 1.8%
Partial Seizures 1.7%
Drug Dependence 1.6%
Grand Mal Convulsion 1.6%
Helicobacter Infection 1.5%
Anxiety 1.3%
Restless Legs Syndrome 1.3%
Drug Interaction 22.6%
Toxicity To Various Agents 13.3%
Epilepsy 6.7%
Drug Toxicity 6.2%
Nystagmus 5.6%
Vomiting 5.6%
Unresponsive To Stimuli 5.1%
Overdose 4.6%
Weight Increased 4.1%
Hyponatraemia 3.1%
Rhabdomyolysis 3.1%
Ataxia 2.6%
Balance Disorder 2.6%
Rash Pruritic 2.6%
Burning Sensation 2.1%
Depressed Level Of Consciousness 2.1%
Dyskinesia 2.1%
Off Label Use 2.1%
Palpitations 2.1%
Somnolence 2.1%